[flagged]
FDA Approves First Oral Treatment for Postpartum Depression
11–20 of 299 posts
Re: FDA Approves First Oral Treatment for Postpartum Depression
#12[flagged]
Or, a helpful drug that helps people in a risky situation.
Re: FDA Approves First Oral Treatment for Postpartum Depression
#13> The primary endpoint of both studies was the change in depressive symptoms using the total score from the 17-item Hamilton depression rating scale (HAMD-17), measured at day 15. Patients in the Zurzuvae groups showed significantly more improvement in their symptoms compared to those in the placebo groups. Why would you mention the number of items on the scale, but not mention the number of points the drug gained? I…
> Why would you mention the number of items on the scale, but not mention the number of points the drug gained? Is it that professionals normally refer to it as the "17-item Hamilton depression rating scale"? Correct. "17-item Hamilton depression rating scale" (or HAMD-17) is the precise name of the scale; "17-item" is required to distinguish it from other variations with different numbers of questions. The precise i…
Apparently the brand name `Zurzuvae` in the first paragraph links to a PDF of the full prescribing info from the FDA. Pages 17-18 list the exact changes in HAM-D score over the first 15 days on the drug and the following 30 days after.
Both Zurzuvae and Placebo showed improvement in HAM-D over the 15 day period, but Zurzuvae showed a greater improvement. (From 28.6 to 13, vs 28.8 to 17.2, for a difference of -4.0 points, where lower is better.)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/21...
Re: FDA Approves First Oral Treatment for Postpartum Depression
#14Earlier quoted context omitted.
> Why would you mention the number of items on the scale, but not mention the number of points the drug gained? Is it that professionals normally refer to it as the "17-item Hamilton depression rating scale"? Correct. "17-item Hamilton depression rating scale" (or HAMD-17) is the precise name of the scale; "17-item" is required to distinguish it from other variations with different numbers of questions. The precise i…
> The precise improvement in scoring is undoubtedly present in the clinical trial paper, but isn't relevant to a FDA press release about their approval of the drug. Exactly. If it isn’t harmful, it doesn’t have to be very helpful — the effect can be small and significant.
FWIW: the full prescribing information warns about risks of physical dependance and withdrawal symptoms. The drug also ends up in the mother's breast milk at low levels. (See full prescribing info PDF linked in the article.)
Re: FDA Approves First Oral Treatment for Postpartum Depression
#15> Use of Zurzuvae may cause suicidal thoughts and behavior. Zurzuvae may cause fetal harm.
Might be better off just smoking a joint.
Re: FDA Approves First Oral Treatment for Postpartum Depression
#16[dead]
Re: FDA Approves First Oral Treatment for Postpartum Depression
#17[flagged]
Re: FDA Approves First Oral Treatment for Postpartum Depression
#18[flagged]
Re: FDA Approves First Oral Treatment for Postpartum Depression
#19> Use of Zurzuvae may cause suicidal thoughts and behavior. Zurzuvae may cause fetal harm. Might be better off just smoking a joint.
We can't have that. Big pharma doesn't get the check.